Cheng J
iHuman Institute, ShanghaiTech University, Shanghai, China. chengjj@shanghaitech.edu.cn.
ArticlePsychedelics
Structure-based design of subtype-selective psychedelic analogs.
ArticlePsychedelics
Mechanistic Basis for 5-HT<sub>2A</sub>R Over 5-HT<sub>2B</sub>R Activation.
ArticleKetamine
Comparison of Ketamine and Pregabalin on Postoperative Opioid Usage and Pain Management in Spinal Fusion: Systematic Review and Network Meta-analysis.
ArticleLSD
Targeting peripheral 5-HT<sub>2A</sub>R enhances antitumor immunity in colorectal cancer.
ArticleMescaline
The Ethnopharmacological Use of Mescaline for Psychiatric Disorders: A Systematic Review.
ArticlePsilocybin
Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects.
ArticleKetamine
Prophylactic esketamine to reduce postpartum depression in primiparae: A multicentre, double-blind, randomised clinical trial.
ArticlePsilocybin
Structure-Guided Design of Novel 5-HT<sub>2A</sub> Partial Agonists as Psychedelic Analogues with Antidepressant Effects.
ArticleKetamine
Inhibition of SERT and NMDAR synergistically confers rapid antidepressant effects of ketamine.
ArticleKetamine
Effect of subanesthetic dose of esketamine on early postoperative depression in elderly patients with Sarcopenia.
ArticleKetamine
Inhibitory effect of low-dose esketamine on cough induced by sufentanil during the induction of anesthesia and postoperative impact on mental health status: a prospective, single-center, randomized controlled trial.
ArticleLSD
Structural basis of psychedelic LSD recognition at dopamine D<sub>1</sub> receptor.
ArticlePsilocybin
Serotonin 2A Receptor (5-HT<sub>2A</sub>R) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.
ArticlePsilocybin